Expansion and Diversification

In response to the constantly changing legal frameworks in the EU and the continuously increasing global demand, we took a decisive step towards North America in 2022. Within our new parent company, an established player in the field of phytopharmaceuticals, we continued our tradition of innovation and strengthened our position as a global player. In doing so, we preserved our independence and the strong identity of ArtemiCure.

Our Products and Innovations

Our flagship product, the 30:1 Artemisia annua full-spectrum capsules, as well as our Artemisinin capsules, exemplify our commitment to quality and innovation. We continuously work on improving and refining our processing methods. By employing state-of-the-art technologies and techniques, we ensure that every product leaving our facility meets our stringent standards.

Sustainability and Responsibility

Sustainability is not just a buzzword for us; it is a core component of our corporate philosophy. Our cultivation areas in Tenerife and partnerships with selected farmers in Europe and North America enable us to protect the environment while ensuring the highest product quality. We are constantly striving to reduce our ecological footprint while simultaneously improving the socioeconomic conditions of our partners.

A Look into the Future

As a leading manufacturer in Europe and the third largest worldwide, ArtemiCure is more than just a name—it is a synonym for trust, quality, and sustainability in the phytopharmaceutical industry. Our journey continues with the goal of enhancing the health and well-being of our customers while respecting and preserving the beauty and power of nature.